Health Feed
US$ 29.26
glp 1 rezeptor antagonist Frontiers GLP-1-Rezeptoragonisten (Inkretinmimetika) | Gelbe Liste
Description
doi:10.1016/j.neubiorev.2021.10.037
Exenatide-loaded nanoparticles have been shown in cell and animal studies to improve glycemic control, reduce insulin resistance, improve lipid profiles, reduce organ damage, and support weight management
10.1136/bjophthalmol-2016-308894
Semaglutide has no structural relationship to any of these compounds
The GLP-1 effect is also influencing consumer behavior and product choices in weight management
